Fig. 1
From: Plerixafor in poor mobilizers with non-Hodgkin’s lymphoma: a multi-center time-motion analysis
Selected outcomes by country; mean numbers are shown for the pre-plerixafor and plerixafor era and standard deviations are depicted as vertical lines. a Mean number of apheresis sessions. b Mean number of minutes spent on apheresis. c Mean number of first apheresis yield. d Mean apheresis costs
